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(ICA) stenosis than younger patients or those with asymptomatic ICA
stenosis or retinal TIA.
Summary: It appears combined stroke and death rates after CAS are
higher in symptomatic than asymptomatic patients (Stroke 2003; 34:813-819).
The authors sought to identify specific clinical risk factors thatmay influence post
procedural complications after CAS. This was a retrospective review of a pro-
spectively maintained database involving 299 patients (217 men, 82 women,
mean age 69  9 years), who underwent CAS for either asymptomatic (n 
129, 43%) or symptomatic (n  170, 57%) ICA stenosis. Logistic regression
analysis was used to determine risk factors associated with peri-procedure
(30-day) complications (any TIA, minor stroke, major stroke or death).
Overall, the 30-day TIA rate was 3.7%. Theminor stroke rate was 5.3%,
and the major stroke rate 0.7%, with a death rate of 0.7%. Patients presenting
with a minor stroke or hemispheric TIA had a higher risk of complication
than asymptomatic patients (odds ratio [OR] 5.69; 95% confidence interval
[CI], 2.03-19.57; P .001). Complication rate in patients presenting with
a retinal TIA and in asymptomatic patients were similar (OR, 1.42; 95% CI,
0.13-9.02; p  0.6). Advanced age (OR 1.06; 95% CI 1-1.11; P  .05),
stroke (OR, 8.0; 95% CI, 2.26-24.1; P .01), or hemispheric TIA (OR 4.7;
95% CI, 1.16-13.3; P .004), were all independent predictors of combined
30-day occurrence of any TIA, stroke, or death.
Comment: Identification of potential risk factors for CAS is crucial to
proper patient selection for CAS and for patient counseling. This study helps
identify presenting clinical features that may be important in selecting the
patients for CAS. Unfortunately, angiographic features of the carotid steno-
ses were not reported. It is likely that a combination of angiographic and
clinical features will ultimately prove most useful in the selection of patients
for CAS.
Post carotid endarterectomy hyperperfusion or reperfusion syndrome?
Karapanayiotides T, Meuli R, Devuyst G, et al. Stroke 2005; 36:21-26
Conclusion: So called hyperperfusion syndrome after carotid endar-
terectomy may, in some cases, be more correctly described as resulting from
reperfusion rather than hyperperfusion.
Summary:Hyperperfusion syndrome (HS) following carotid revascu-
larization is thought to occur in a previously chronically hypoperfused
cerebral hemisphere with impaired cerebrovascular autoregulation. The
authors of this study sought to study hemispheric perfusion in patients
following carotid endarterectomy who had symptoms consistent with so-
called HS. Patients were selected from 388 consecutive patients who under-
went carotid endarterectomy. Five of these patients presented 2-7 days after
carotid endarterectomy with partial seizures and focal neurologic deficits.
Three had a cerebral hemorrhage. These patients were considered to have
HS. All had undergone carotid endarterectomy for very high-grade carotid
stenosis. Patients were assessed for relative inter-hemispheric differences of
cerebral blood flow by perfusion weighted MRI imaging and with diffusion
weighted (DWI) MRI imaging. In addition, middle cerebral blood flow
velocity measurements were obtained with transcranial Doppler.
There were no hyper-intensity pathologic DWI abnormalities in any of
the five patients. This is consistent with an absence of acute ischemic or
cytotoxic hemispheric edema. Perfusion weighted imaging documented a
20-44% relative inter-hemispheric difference in cerebral blood flow in favor
of the hemisphere ipsilateral to the recent carotid endarterectomy. Transcra-
nial Doppler middle cerebral artery flow velocities were not abnormally
increased in any patient.
Comment: The classic definition of HS following carotid endarterec-
tomy is a 100% increase in cerebral blood flow compared to preoperative
values (J Neurosurg 2003; 99:504-510). The current study suggests symp-
toms and pathology consistent with what is regarded asHS following carotid
endarterectomy can occur in the presence of relatively mild increased cere-
bral perfusion. The hemodynamic abnormalities leading to the clinical
manifestations of HS may be milder and more complicated than previously
appreciated.
Risk factors for venous thrombosis in swedish children and adolescents
Rask O, Berntorp E, Ljung R. ACTA Paediatrica 2005:94:717-22
Conclusion: There are prothrombotic risk factors present in almost all
children and adolescents with venous thrombosis.
Summary: Venous thrombosis has an incidence of approximately
10/10,000 in adults and 0.07/10,000 children. (Haematologica 1999;84:
59-70 and Journal Pediatr Hematol Oncol 1997;19:7-22). Little informa-
tion, however, exists regarding prothrombotic risk factors in children with
venous thromboembolism (VTE). The authors attempted to identify pro-
thrombotic risk factors in adolescents and children following their first VTE
event. There were 128 consecutive adolescents and children (newborn to 20
years) who were evaluated following referral to a regional coagulation center
in southern Sweden. The prothrombotic risk factors evaluated included
protein C, protein S, antithrombin; resistant to activated protein C; geno-
types FV – G1691A, II-G20210A, MTHFR-C677T, MTHFR-A1298C,
and coagulation factors VIII and XI. There was also a retrospective collec-
tion of clinical data.Identifiable genetic factors related to VTE were present in 53 of 83
(64%) subjects who had follow up blood sampling. Of these 17/83 (20%)
had two or more inherited risk factors. There was a combination of acquired
risk factors and genetic risk factors in 45/83 subjects (54%). At least 1 risk
factor was present in 77/83 subjects (93%). There was a peak frequency of
VTE in children less than 1 year of age with a second peak occurring during
adolescents. Levels of coagulation factors VIII and XI were age appropriate
and showed a normal Gaussian distribution.
Comment:While venous thromboembolism is unusual in children and
adolescents, the data here suggest that a VTE event in a child should be
investigated with a detailed hypercoagulable panel. The yield is high enough
to merit routine use in children with VTE.
Changes in false lumen after transluminal stent-graft placement in
aortic dissections six years experience
Kusagawa H, Shimono T, Ishieda M et al. Circulation 2005;111:2951-7
Conclusion: Treatment of aortic dissection with stent graft placement
results in obliteration of the false lumen more often in the acute setting than
in chronic dissections.
Summary: The authors chose to review their aortic stent graft patients
where stent grafts were placed for treatment of aortic dissection. The goal was to
quantify long term results in changes in the false lumen over time. There were
49 patients who had primary tears in the descending aorta who were treated
with aortic stent graft placement. Followup ranged from4months to 6 years. In
thirty-two cases the patients were treated in the acute setting and there were 17
chronic dissections treated. In the acute cases there were 15 retrograde dissec-
tions (Stanford type A) treated. Patients were followed with serial CT scans.
In patients with Stanford type A retrograde dissections treated with
stent grafts the false lumen in the ascending aorta was obliterated within
three months in 93% of the cases. Serial CT scans of 17 acute dissections and
11 chronic dissections showed the average false lumen diameter of the
proximal mid and distal descending aorta in the acute dissection group was
15.9, 16.2, and 15.6mm respectively. In the chronic dissection group the
average false lumen diameters of the proximal mid and distal descending
aorta were 28.1, 25.2, and 21.0mm respectively. After 2 years the false
lumen in the thoracic aorta was completely obliterated in 76% of the acute
dissections and 36% of the chronic dissections treated with stent grafts.
There were no cases of late rupture.
Comment: The study suggests a move towards more interventional
treatment of acute thoracic dissection. Certainly, the success of obliterating
the retrograde dissection into the aortic arch from a descending primary tear
suggests that acute treatment of Type B dissections will be considered and
performed in additional locations. Medical management of Type B dissec-
tion is highly effective but the fact that the chronic dissections have more
difficulty in late obliteration of the false lumen after treatment with stent
grafts suggests that it may be prudent to eventually treat Type B dissections
acutely with stent graft placement.
Aortic neck attachment failure and the aneurx graft: incidence, treat-
ment options, and early results
Azizzadeh A, Sanchez LA, Rubin BG, et al. Annals Vascular Surgery
2005;19:516-21
Conclusion: Proximal attachment failure associated with the AneuRx
endoluminal aortic stent graft is relatively uncommon and associated with
unfavorable neck anatomy.
Summary: The frequency of proximal attachment failure associated with
the AneuRx aortic stent graft is unclear. The authors evaluated the need for
intervention in patients with suboptimal proximal fixation of an AneuRx stent
graft. They assessed the feasibility and early success of a variety of treatment
strategies. There were 365 endovascular aneurysm repairs performed using the
AneuRxgraft fromOctober 1999 toOctober 2003.Mean followupwas 23.7
14.8 months. There were 20 patients considered for treatment following stent
grafting. Fourteen had a Type 1 endoleak, one had a Type 3 endoleak, and five
had an inadequate proximal seal zone (less than 1cm). Of these patients, 18
(90%) were treated successfully. (Nine with AneuRx cuffs, six with Talent cuffs,
five with aortic stents, one with a redo aortic endograft, and two with surgical
conversion.) Of the 20 patients with suboptimal initial outcome, one refused
treatment and suffered late aneurysm rupture and one had persistent Type 1
endoleak despite endovascular treatment. Following the secondary interven-
tion, there were no further endoleaks or graft migrations detected at a mean
followup of 13.9 11.8 months.
Comment: Followup periods in this study are relatively short, with a
mean followup of 23.7  14.8 months following initial placement of the
AneuRx stent graft and a mean followup of only 13.9  11.8 months
following secondary intervention in 20 patients with suboptimal proximal
fixation. Likely there will be more proximal attachment site failures as time
goes by. The follow-up periods presented here are simply too short to
suggest either continued use of or immediate abandonment of the AneuRx
graft system. Longer term data is required. A comparison of rates of proximal
site attachment rate failure with other types of aortic stent grafts is also
required.
